Newstral
Article
The New York Times on 2023-09-29 21:42
F.D.A. Moves to Regulate Lab Tests That It Says Put Patients ‘at Risk’
Related news
- Weak lab oversight might put patients at riskKnoxville News Sentinel
- Lab-Grown Meat Receives Clearance From F.D.A.The New York Times
- F.D.A. Moves to Change ‘Healthy’ Food DefinitionThe New York Times
- Small lab that got $187 million for COVID testing put patients in jeopardy, feds sayAlaska Dispatch News
- FDA Wants to Oversee Lab Tests It Says Put Patients ‘At Risk’The New York Times
- Miami moves to regulate dronesmiamitodaynews.com
- F.D.A. Approves First Drug for Treating Coronavirus Patientsherald.co.zw
- F.D.A. Warns Patients About Some Prenatal Genetic TestsThe New York Times
- Lasik Patients Should Be Warned of Complications, F.D.A. Draft SaysThe New York Times
- F.D.A. Aims to Speed Extra Vaccine Doses for Immunocompromised PatientsThe New York Times
- OState Lab Moves Forwardourherald.com
- F.D.A. Allows Expanded Use of Plasma to Treat Coronavirus PatientsThe New York Times
- Patients Must Be Warned of Breast Implant Risks, F.D.A. SaysThe New York Times
- F.D.A. Moves to Restrict Flavored E-Cigarette Sales to TeenagersThe New York Times
- F.D.A. Moves to Ban Sales of Menthol CigarettesThe New York Times
- F.D.A. Moves to Stop Use of Unapproved Stem Cell TherapiesThe New York Times